obsolete_incontinentia pigmenti achromians: a dermal melanocytic condition affecting the shoulder area. Nevus of Ito often occurs in association with nevus of Ota in the same patient but is much less common, although the true incidence is unknown.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
760 |
4. Check minimum number of eventsNone |
760 |
5. Include endpointsNone |
760 |
6. Filter based on genotype QC (FinnGen only) |
760 |
Control definitions (FinnGen only)
- Control exclude
- L12_OTHERSKINSUBCUTIS
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L81
- Name in latin
- Alia hyperpigmentatio melaninalis
Similar endpoints
↥List of similar endpoints to
Other melanin hyperpigmentation
based on the number of shared cases.
Similar with more cases:
- Other disorders of pigmentation
- Other disorders of skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5087 | 3489 | 1584 |
| Only index persons | 4808 | 3344 | 1464 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.08 | 0.10 | 0.04 |
| Only index persons | 0.10 | 0.12 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 65.20 | 65.37 | 65.10 |
| Only index persons | 65.53 | 65.39 | 65.84 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 760 | 503 | 257 |
| Unadjusted period prevalence (%) | 0.15 | 0.17 | 0.11 |
| Median age at first event (years) | 64.62 | 62.77 | 68.23 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 669
- Matched controls
- 6689
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
4503599627370496.0
323.0
668
6
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
17.2
169.0
294
292
L57.0
ICD-10 Finland
Actinic keratosis
11.3
127.1
271
380
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
8.6
55.3
128
179
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
15.9
52.9
88
63
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.0
48.1
146
297
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
13.9
43.9
77
62
L82
ICD-10 Finland
Seborrhoeic keratosis
4.3
43.6
186
544
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
31.7
37.9
50
17
XQ848
NOMESCO Finland
Dermatological photography
11.9
34.7
65
60
R23.8
ICD-10 Finland
Other and unspecified skin changes
3.6
33.6
180
625
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
10.6
31.3
62
64
ZXC50
NOMESCO Finland
Cryotherapy
8.7
29.9
66
83
XQ845
NOMESCO Finland
Dermatoscopy
16.7
27.6
44
28
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
40.6
25.1
31
8
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
4.5
24.9
93
230
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
7.5
23.7
57
82
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
15.3
23.7
39
27
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
6.2
22.7
63
111
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
10.2
22.1
44
46
TQW99
NOMESCO Finland
Other minor procedure on skin
4.8
20.1
69
156
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
7.3
19.0
46
67
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.9
18.5
79
221
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
4.9
17.6
59
130
SPAT1153
SPAT
Removal of sutures
2.1
17.1
263
1574
ZXC20
NOMESCO Finland
Use of chemical agents
7.6
15.9
37
51
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
7.3
15.6
37
53
S18
ICPC
Laceration/cut
1.9
14.9
306
2024
D06BB10
ATC
imiquimod; topical
4.4
14.7
54
131
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
18.0
13.9
21
12
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
15.4
13.2
21
14
ZXC15
NOMESCO Finland
Use of photodynamic technique
7.6
13.1
30
41
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
14.4
12.8
21
15
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
14.4
12.8
21
15
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
20.5
12.5
18
9
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
9.2
12.3
25
28
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
5.9
11.8
32
56
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
4.4
11.8
42
100
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
20.4
11.2
16
8
L04AA01
ATC
[U] ciclosporin; systemic
8.8
11.1
23
27
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
14.2
11.0
18
13
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
6.7
10.9
27
42
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
28.5
10.8
14
5
L04AD01
ATC
ciclosporin; systemic
6.5
10.7
27
43
L81.1
ICD-10 Finland
Chloasma
33.1
10.4
13
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.1
10.1
123
649
ZZR00
NOMESCO Finland
Flap of skin
6.1
9.9
26
44
A02BC05
ATC
esomeprazole; systemic
1.7
9.6
293
2106
127
Kela drug reimbursment
Transplant complication
6.8
9.5
23
35
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
4.0
9.4
36
93
E0000UV
ATC
NA
1.7
9.4
252
1741
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
7.9
9.2
20
26
L04AA06
ATC
mycophenolic acid; systemic
6.5
8.8
22
35
A98
ICPC
Health maint/preventive medicine
2.7
8.8
636
5878
TQW80
NOMESCO Finland
Local dermatologic skincare
5.2
8.7
26
52
D03.5
ICD-10 Finland
Melanoma in situ of trunk
50.7
8.7
10
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
7.8
8.7
19
25
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
2.7
8.6
59
234
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
20.3
8.5
12
6
8742/2-C44.9
ICD-O-3
Lentigo maligna of skin, NOS
91.2
8.4
9
*
-
ICD-10 Finland
NA
4.4
8.4
29
68
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
10.9
8.3
15
14
Z94.0
ICD-10 Finland
Kidney transplant status
7.7
8.2
18
24
L85.3
ICD-10 Finland
Xerosis cutis
17.4
8.1
12
7
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
33.8
8.1
10
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
6.0
7.7
20
34
L91.0
ICD-10 Finland
Hypertrophic scar
25.3
7.6
10
*
D06BX02
ATC
ingenol mebutate; topical
5.5
7.6
21
39
S29
ICPC
Skin symptom/complaint other
1.9
7.5
120
695
40399
ICD-8 Finland
Hypertensive renal disease
+∞
7.3
7
*
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.2
7.3
72
344
R51.80
ICD-10 Finland
Headache
2.0
7.2
90
475
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
30.4
7.2
9
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
12.2
7.1
12
10
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
8.9
7.1
14
16
E000006
ATC
NA
2.4
7.1
59
262
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
7.0
146
924
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
6.9
381
3088
ZXA00
NOMESCO Finland
Right side
1.6
6.9
193
1325
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
6.9
229
1645
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
5.4
6.8
19
36
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
40.5
6.8
8
*
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
6.7
189
1299
L14
ICPC
Leg/thigh symptom/complaint
2.3
6.7
57
255
KMAK
NOMESCO Finland
NA
1.5
6.7
305
2362
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
6.6
420
3503
L04AX01
ATC
azathioprine; systemic
3.2
6.5
32
104
L01BB01
ATC
NA
70.5
6.4
7
*
4056
NOMESCO Finland
NA
70.5
6.4
7
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
3.1
6.4
32
105
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.8
6.4
39
146
E000001
ATC
NA
1.7
6.4
127
791
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
6.3
292
2260
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
9.4
6.3
12
13
C44.20
ICD-10 Finland
Malignant tumor of the skin of the outer ear and of the outer ear canal without histology
+∞
6.3
6
*
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
26.9
6.2
8
*
SPAT1301
SPAT
No procedures
1.6
6.1
214
1549
D10AX03
ATC
azelaic acid; topical
3.1
6.1
31
103
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
4.4
6.1
20
46
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
8.7
6.1
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
384
2480
2.11
22.26
3.0
2.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
224
1283
2.06
16.95
5.4
4.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
441
3203
1.90
16.28
6.8
5.5
e9/l
0.2
0.2
0.18
400
2785
(3001604) Monocytes [#/volume] in Blood
427
3075
1.89
16.12
6.7
5.3
e9/l
0.6
0.6
2.19
381
2622
(3006315) Basophils [#/volume] in Blood
428
3090
1.88
15.98
6.7
5.3
e9/l
0.0
0.0
0.05
382
2644
(40768443) Skin Pathology biopsy report
70
242
3.08
15.82
1.2
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
430
3143
1.85
15.08
6.8
5.4
e9/l
1.8
1.9
1.27
394
2740
(3002385) Erythrocyte distribution width [Ratio]
620
5118
2.15
14.99
20.1
18.4
%
13.8
13.8
0.00
609
5001
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
377
2712
1.77
13.33
2.3
2.2
nmol/l
79.6
79.6
0.01
338
2380
(3018418) pH of Serum or Plasma
302
2061
1.77
12.62
5.0
3.8
ph
7.4
7.4
0.06
49
401
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
593
5019
1.83
10.58
8.1
7.3
u/l
75.9
78.6
1.14
558
4672
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
729
6675
3.26
10.46
12.0
10.6
u/l
23.8
24.5
0.72
702
6416
(3013650) Neutrophils [#/volume] in Blood by Automated count
457
3623
1.66
10.14
9.5
8.8
e9/l
3.8
4.1
2.52
413
3170
(3035350) Ketones [Presence] in Urine by Test strip
403
3130
1.61
9.42
5.0
3.9
estimate
0.0
0.0
0.00
78
588
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
428
3390
1.60
9.09
7.8
6.2
mmol/l
1.2
1.2
0.06
371
2858
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
398
3106
1.59
8.94
6.5
5.5
mmol/l
1.2
1.2
0.42
365
2806
(3007461) Platelets [#/volume] in Blood
738
6884
3.49
8.65
25.2
21.8
e9/l
242.6
249.0
1.98
722
6680
(3035941) MCH [Entitic mass]
738
6886
3.48
8.61
25.0
21.7
pg
30.4
30.3
0.48
729
6762
(3024731) MCV [Entitic volume]
738
6886
3.48
8.61
25.1
21.8
fl
91.5
91.4
0.08
729
6763
(3010813) Leukocytes [#/volume] in Blood
738
6887
3.47
8.58
25.2
21.9
e9/l
6.5
6.7
2.10
719
6657
(3026361) Erythrocytes [#/volume] in Blood
738
6887
3.47
8.58
25.2
21.8
e12/l
4.4
4.4
0.27
721
6663
(3021601) Nitrite [Presence] in Urine by Test strip
401
3154
1.57
8.57
6.4
5.4
estimate
0.0
0.0
0.00
82
581
(3000963) Hemoglobin [Mass/volume] in Blood
738
6889
3.46
8.54
25.2
22.0
g/l
134.0
133.2
0.89
730
6761
(3009261) Glucose [Presence] in Urine by Test strip
404
3187
1.57
8.50
5.1
3.9
estimate
0.0
0.0
0.50
78
571
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
322
2418
1.58
8.36
5.2
4.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
717
6608
2.50
8.29
20.1
17.4
mmol/l
4.0
4.0
0.05
698
6415
(3026389) Candida sp identified in Specimen by Organism specific culture
26
75
3.55
7.88
1.7
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
623
5498
1.74
7.86
17.9
16.3
%
39.2
39.0
0.18
377
3616
(40761511) CBC panel - Blood by Automated count
705
6473
2.23
7.85
16.5
14.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
557
4778
1.62
7.82
5.2
4.1
mm/h
12.2
13.5
1.12
519
4375
(3002256) Pathology report gross observation
133
808
1.78
7.80
1.7
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
204
1393
1.63
7.78
5.5
4.2
kg/l
1.0
1.0
0.19
16
205
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
694
6339
2.09
7.76
5.9
5.2
mmol/l
2.6
2.7
1.08
634
5755
(3019550) Sodium [Moles/volume] in Serum or Plasma
712
6594
2.26
7.23
19.9
17.3
mmol/l
139.9
139.7
1.20
693
6410
(3031040) Bacteria [#/volume] in Urine by Automated count
509
4313
1.55
7.18
5.8
4.7
e6/l
4321.1
3094.5
—
7
70
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
652
5872
1.78
7.10
5.8
4.9
mu/l
2.0
1.9
0.06
603
5297
(3044889) 12 lead EKG panel
538
4623
1.56
7.05
5.1
4.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
678
6192
1.88
6.85
5.2
4.6
mmol/l
4.6
4.7
0.86
627
5658
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
654
5924
1.75
6.60
6.5
6.1
mmol/mol
39.1
40.2
3.37
611
5434
(3029937) Albumin [Presence] in Urine by Test strip
235
1722
1.53
6.43
5.8
4.1
estimate
0.0
0.0
0.50
78
558
(3003458) Phosphate [Moles/volume] in Serum or Plasma
131
837
1.68
6.36
6.6
4.5
mmol/l
1.0
1.0
0.36
122
756
(3037467) Urinalysis macro (dipstick) panel - Urine
514
4423
1.50
6.25
5.6
4.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
353
2823
1.47
6.24
7.3
5.5
%
0.7
0.7
1.25
329
2613
(3024561) Albumin [Mass/volume] in Serum or Plasma
360
2890
1.47
6.24
5.5
4.3
g/l
35.9
35.2
1.40
327
2673
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
561
4919
1.54
6.22
4.8
4.0
pmol/l
14.9
15.0
0.14
512
4413
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
676
6209
1.80
6.13
5.4
4.9
mmol/l
5.8
6.0
5.40
614
5583
(3015377) Calcium [Moles/volume] in Serum or Plasma
298
2315
1.47
6.06
3.4
3.4
mmol/l
2.3
2.4
1.01
265
2015
(3020564) Creatinine [Moles/volume] in Serum or Plasma
712
6666
2.08
5.84
20.3
17.6
umol/l
81.8
77.1
2.14
712
6666
(3021589) Normoblasts [#/volume] in Blood
346
2781
1.45
5.83
10.8
9.6
e9/l
0.0
0.0
0.77
297
2278
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
27
97
2.85
5.78
8.8
5.0
iu/ml
98.2
660.6
—
5
13
(3000494) Fungus identified in Specimen by Culture
118
753
1.67
5.74
1.7
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
92
548
1.77
5.73
4.0
3.3
ng/l
98.6
82.5
0.85
84
472
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
668
6140
1.73
5.70
5.0
4.6
mmol/l
1.5
1.5
1.19
607
5556
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
42
847
0.47
5.65
4.6
4.7
%
34.0
33.3
0.13
29
552
(3001122) Ferritin [Mass/volume] in Serum or Plasma
324
2586
1.44
5.60
3.1
2.7
ug/l
110.2
128.5
1.10
295
2338
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
675
6230
1.75
5.57
16.5
14.6
mg/l
22.5
24.3
0.78
537
4957
(3037522) Nuclear Ab [Titer] in Serum
116
743
1.66
5.56
1.4
1.3
titre
958.3
545.6
0.69
24
161
(3006504) Eosinophils/100 leukocytes in Blood
356
2905
1.42
5.39
7.4
5.5
%
2.8
2.8
0.16
330
2689
(3000850) Epithelial cells [#/volume] in Urine
192
1394
1.50
5.36
3.6
2.4
e6/l
4.3
6.3
1.43
169
1237
(3019069) Monocytes/100 leukocytes in Blood
357
2918
1.42
5.33
7.7
5.8
%
9.0
8.7
0.73
333
2715
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
648
5935
1.62
5.29
4.5
4.1
mmol/l
1.2
1.3
1.82
584
5327
(3025941) Bacteria identified in Stool by Culture
60
321
1.94
5.24
1.4
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
85
509
1.75
5.20
2.7
2.7
ml/min/173m2
65.4
62.0
0.34
41
211
(3041096) Erythrocytes [Presence] in Urine by Automated
222
1675
1.46
5.08
4.0
3.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
361
2974
1.41
5.07
7.5
5.7
%
27.3
27.3
0.05
336
2746
(3026782) Osmolality of Urine
185
1347
1.49
5.06
3.4
2.7
mosm/kgh2o
532.6
538.5
0.15
155
1148
(3030467) Casts [#/volume] in Urine by Automated count
239
1831
1.45
5.04
4.0
3.0
e6/l
0.3
0.5
1.68
186
1380
(3018095) Leukocytes [#/volume] in Urine
289
2296
1.42
4.97
5.2
3.7
e6/l
46.7
87.7
1.05
218
1649
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
261
2049
1.42
4.76
2.9
2.4
u/l
58.9
57.4
0.30
233
1871
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
33
146
2.32
4.70
3.8
3.0
mg/l
1.8
1.7
0.15
28
132
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
108
715
1.60
4.52
2.4
2.5
umol/l
6.3
7.9
0.94
95
619
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
178
1313
1.46
4.52
3.7
4.0
ng/l
238.2
314.8
0.27
148
1070
(3018010) Neutrophils/100 leukocytes in Blood
352
2926
1.38
4.51
7.4
5.5
%
57.0
57.7
0.54
329
2727
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
254
2002
1.40
4.48
2.4
2.1
u/l
172.4
203.7
0.36
233
1879
(42870588) Differential panel, method unspecified - Blood
266
2114
1.40
4.46
6.7
5.3
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
20
72
2.83
4.31
1.1
1.1
g/l
1.5
1.5
0.11
20
64
(3018677) aPTT in Platelet poor plasma by Coagulation assay
139
985
1.50
4.29
1.9
1.8
s
30.6
29.5
0.99
133
952
(40761535) Cells panel - Urine sediment
86
551
1.63
4.12
4.8
3.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
145
1045
1.48
4.12
4.5
3.0
mmol/l
0.8
0.8
0.37
133
980
(36304419) Bacteria [Presence] in Urine
226
1773
1.39
4.02
4.1
3.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
439
3821
1.35
4.01
5.2
4.5
mmol/l
6.5
6.7
1.44
423
3572
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
223
1748
1.39
3.99
1.7
1.6
mmol/l
1.2
1.3
1.16
175
1452
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
399
3435
1.34
3.86
6.4
6.0
umol/l
12.0
11.3
0.84
375
3252
(3011397) Hemoglobin [Presence] in Urine by Test strip
194
1496
1.40
3.80
5.4
3.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
248
1992
1.36
3.78
4.6
3.1
e6/l
16.7
91.3
1.57
200
1541
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
8
8.82
3.78
3.4
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
328
2755
1.34
3.71
12.0
9.8
inr
1.2
1.3
0.28
105
786
(3038177) Helicobacter pylori Ab [Presence] in Serum
20
80
2.54
3.57
1.2
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
142
1051
1.43
3.49
1.3
1.3
iu/ml
43.1
34.8
0.19
44
345
(3008152) Bicarbonate [Moles/volume] in Arterial blood
69
438
1.63
3.45
5.3
6.7
mmol/l
24.3
24.6
0.27
64
411
(3026493) Urate [Moles/volume] in Serum or Plasma
206
1638
1.35
3.29
4.0
2.6
umol/l
5368.3
8541.6
0.48
181
1392
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22
97
2.31
3.22
1.3
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
85
578
1.53
3.19
2.5
1.9
nmol/l
384.7
384.7
0.00
80
524
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
126
933
1.42
3.08
1.5
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
71
468
1.57
3.06
4.0
4.6
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
8
7.55
3.06
4.0
6.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
169
1317
1.36
3.05
2.9
3.0
mmol/l
2.4
2.5
0.71
148
1173
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
110
796
1.45
3.05
1.9
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
198
1585
1.34
3.00
7.7
6.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
379
3315
1.29
2.97
2.8
2.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
110
802
1.43
2.93
1.8
1.7
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
83
574
1.50
2.89
3.0
3.0
g/l
65.9
66.8
0.49
76
518
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
82
566
1.50
2.88
2.1
2.5
ug/l
9.3
7.1
0.39
69
492
(3007853) Bacteria identified in Skin by Aerobe culture
93
659
1.47
2.88
2.0
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
145
1117
1.37
2.81
1.8
1.5
g/l
2.5
2.6
0.19
96
637
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
241
2001
1.30
2.79
3.8
3.1
u/l
31.0
31.8
0.14
227
1902
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
48
2.74
2.73
1.0
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
56
361
1.60
2.68
2.7
3.0
pmol/l
4.3
4.5
0.57
47
315
(3017181) Myelocytes/100 leukocytes in Blood
78
543
1.49
2.65
4.7
3.7
%
1.2
1.0
0.14
21
155
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
56
363
1.59
2.62
2.3
2.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
71
486
1.51
2.61
4.0
3.6
%
1.1
0.6
0.38
14
115
(3019225) pH of Specimen
42
670
0.61
2.61
5.3
3.9
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
86
613
1.45
2.59
4.0
3.0
ng/l
175.0
216.5
0.69
76
565
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
56
367
1.57
2.51
1.2
1.2
iu/ml
100.1
149.2
0.67
19
140
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
20
95
2.14
2.50
1.3
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
324
2826
1.26
2.45
2.2
2.1
pmol/l
100.5
94.4
1.32
155
1407
(3049717) Cytology report of Urine Cyto stain
42
258
1.66
2.44
2.4
2.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
122
939
1.36
2.38
3.0
2.3
g/l
2.4
2.3
0.38
109
866
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
200
1652
1.29
2.36
2.3
2.1
mg/l
2.8
3.1
1.03
172
1392
(3012501) Base excess in Blood by calculation
27
147
1.87
2.35
2.2
4.7
mmol/l
2.9
2.9
0.01
12
99
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
162
1303
1.31
2.34
1.2
1.2
u/ml
0.7
1.8
1.75
45
328
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
140
1105
1.33
2.31
3.6
2.7
e6/l
0.7
1.1
2.54
94
611
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
19
92
2.09
2.28
1.7
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
32
186
1.75
2.28
3.2
3.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
120
1526
0.75
2.27
2.2
2.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
18
3.91
2.25
2.9
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
69
486
1.46
2.23
4.8
3.8
%
0.1
0.1
0.07
16
122
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
33
195
1.72
2.22
1.2
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
29
165
1.79
2.22
2.3
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
42
2.64
2.19
1.2
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
15
67
2.26
2.18
1.2
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
117
908
1.34
2.17
2.2
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
109
837
1.35
2.16
10.4
7.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
71
507
1.44
2.15
4.6
3.8
%
0.3
0.1
0.47
18
139
(40768797) Stomach Pathology biopsy report
120
936
1.33
2.15
1.4
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
129
1018
1.32
2.13
3.1
2.3
umol/l
12.5
12.6
0.02
116
936
(40761536) Microorganisms panel - Urine sediment
76
551
1.42
2.12
4.7
4.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
255
2195
1.24
2.10
3.8
3.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
36
222
1.65
2.09
1.7
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
73
528
1.42
2.07
1.6
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
113
883
1.33
2.00
3.2
2.3
%
21.8
22.0
0.05
85
752
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
424
3864
1.22
1.98
3.1
3.1
u/l
46.6
47.9
0.12
388
3551
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
16
3.77
1.94
1.3
3.0
%
115.5
121.5
—
6
16
(3014765) Yersinia sp identified in Stool by Organism specific culture
32
196
1.66
1.93
1.2
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
17
85
2.02
1.91
1.1
1.2
u/ml
332.4
275.4
—
10
49
(3048929) Epstein Barr virus Ab [Presence] in Serum
22
121
1.84
1.90
1.0
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
137
1108
1.29
1.90
1.8
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
32
197
1.65
1.89
1.2
1.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
44
294
1.53
1.87
1.8
1.9
g/l
1.5
1.5
0.15
36
259
(3027801) Oxygen [Partial pressure] in Arterial blood
101
785
1.33
1.86
6.0
6.8
kpa
12.2
12.1
0.08
92
753
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
101
785
1.33
1.86
6.0
6.8
kpa
5.0
5.1
0.78
92
754
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
28
2.88
1.86
1.1
1.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
79
591
1.38
1.86
3.1
3.6
mmol/l
1.2
1.2
0.16
67
516
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
22
122
1.83
1.86
1.1
1.3
miu/ml
345.1
232.7
—
9
60
(4035726)
77
574
1.38
1.86
1.6
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
87
1.98
1.81
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
39
256
1.55
1.80
1.4
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
29
2.78
1.79
1.6
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
213
1826
1.23
1.79
4.3
4.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
197
1677
1.24
1.77
1.5
1.5
nmol/l
25.8
21.5
1.22
174
1401
(3003396) Base excess in Arterial blood by calculation
100
784
1.32
1.75
6.1
6.8
mmol/l
2.0
1.4
1.57
69
621
(3007566) Smooth muscle Ab [Titer] in Serum
24
140
1.74
1.73
1.2
1.2
titre
60.0
67.0
—
7
10
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
7
24
2.93
1.72
1.0
2.0
nmol/l
1.1
9.7
—
7
18
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
25
149
1.70
1.68
2.2
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
19
3.17
1.66
2.0
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
103
820
1.30
1.62
1.6
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
90
706
1.31
1.58
1.9
2.2
ug/g
84.4
132.1
1.94
69
557
(3009214) Lutropin [Units/volume] in Serum or Plasma
17
92
1.87
1.57
1.1
1.2
u/l
17.5
11.4
0.83
17
71
(3020682) Albumin/Creatinine [Ratio] in Urine
242
2129
1.20
1.55
4.2
3.9
mg/mmol
13.6
7.8
0.55
139
1287
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
27
169
1.62
1.54
1.6
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
229
2006
1.20
1.53
3.5
3.2
mg/l
1147.4
333.5
0.72
124
1211
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
76
585
1.33
1.53
1.6
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
95
756
1.29
1.51
3.3
2.5
%
1.8
1.8
0.06
84
671
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
52
378
1.40
1.49
7.1
8.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
50
361
1.41
1.49
1.3
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
235
2069
1.20
1.48
3.5
3.0
mmol/l
6.7
6.9
0.31
195
1709
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
191
1652
1.21
1.45
6.0
5.3
ug/l
2.4
3.2
0.70
169
1470
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
126
1045
1.25
1.43
4.0
2.8
e6/l
2.1
2.6
0.61
80
556
(3017704) Immunofixation for Urine
9
40
2.26
1.40
2.4
1.6
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
46
2.19
1.40
1.5
1.4
g/l
0.9
1.0
—
10
46
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
13
67
1.96
1.39
1.4
2.2
u/l
8312.2
4344.9
—
6
23
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
33
223
1.50
1.38
2.9
3.0
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
82
649
1.30
1.37
6.5
7.1
g/l
115.4
119.5
1.23
77
627
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
121
1005
1.24
1.36
1.3
1.3
u/ml
20.2
11.9
0.45
52
361
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
37
257
1.46
1.36
1.2
2.0
u/l
35.2
39.7
0.55
29
226
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
20
120
1.68
1.35
3.8
2.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
18
295
0.60
1.34
3.0
3.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
74
580
1.31
1.33
3.0
2.3
u/l
39.1
35.7
0.27
59
486
(3014271) Vancomycin [Susceptibility]
0
41
0.00
1.31
0.0
2.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
226
2003
1.18
1.31
3.6
3.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
34
2.37
1.29
4.9
2.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
48
2.10
1.28
1.2
1.3
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
15
84
1.80
1.28
1.1
1.3
mu/l
18.3
45.5
1.15
15
76
(3016502) Oxygen saturation in Arterial blood
87
702
1.27
1.26
6.2
7.1
%
96.7
95.6
2.04
82
676
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
79
631
1.28
1.25
1.5
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
25
163
1.55
1.24
4.6
4.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
15
85
1.78
1.23
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
88
714
1.26
1.23
3.6
3.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
26
2.32
1.19
1.0
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
41
300
1.39
1.17
1.3
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
28
402
0.68
1.17
3.0
3.5
ph
7.4
7.4
—
6
52
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
285
2595
1.16
1.16
3.8
3.8
ng/l
30.8
51.8
0.87
197
1893
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
36
0.00
1.14
0.0
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
159
1385
1.19
1.12
1.6
1.6
mg/l
1.1
1.3
0.24
119
1061
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
13
73
1.79
1.11
2.7
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
31
2.27
1.10
1.1
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
71
570
1.27
1.09
2.6
2.5
e9/l
73.9
69.5
0.47
52
445
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
27
384
0.69
1.08
3.1
3.4
mmol/l
1.9
2.0
0.08
19
290
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
15
89
1.70
1.08
1.5
1.2
nmol/l
0.7
0.6
0.30
15
84
(3051611) Lipemic interference index of Serum or Plasma
11
59
1.88
1.07
4.6
2.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
180
2024
0.85
1.06
2.2
2.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
31
220
1.43
1.06
4.1
4.1
mg/l
37.9
83.5
0.90
23
177
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
31
220
1.43
1.06
4.0
4.2
mg/l
35.2
51.2
0.46
23
178
(46235355) HIV 1 and 2 tests - Meaningful Use set
83
682
1.24
1.06
1.9
1.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
33
2.13
1.05
3.9
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
26
369
0.69
1.04
1.7
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
51
395
1.31
1.04
1.1
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
9
46
1.97
1.04
1.0
1.1
—
84.3
—
0
7
(3000570) Elastase.pancreatic [Mass/mass] in Stool
28
196
1.44
1.03
1.5
1.5
ug/g
255.9
271.4
0.18
19
122
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
7
35
2.01
1.00
2.1
2.1
%
13.6
13.3
—
7
35
(36660697) Celiac disease serology panel - Serum
57
451
1.29
1.00
1.1
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
11
61
1.82
0.99
2.7
2.6
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
5
23
2.18
0.98
1.0
1.0
mg/l
53.6
82.0
—
5
18
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
30
0.00
0.97
0.0
2.4
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
7
36
1.95
0.97
1.0
1.1
—
9.7
—
0
8
(3016650) Hepatitis A virus Ab [Presence] in Serum
14
85
1.66
0.94
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
37
1.90
0.94
2.7
2.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
8
143
0.55
0.94
3.0
2.0
g/l
128.1
129.4
—
8
102
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
28
2.15
0.91
2.3
2.1
u/ml
888.7
1234.0
—
6
28
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
17
110
1.56
0.91
2.2
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
39
297
1.33
0.91
2.5
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
40
307
1.32
0.89
2.1
1.9
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
103
1.57
0.88
1.4
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
8
43
1.87
0.87
1.6
1.6
—
—
—
0
0
(44790047)
12
72
1.68
0.85
2.8
1.4
—
—
—
0
0
(44790048)
12
72
1.68
0.85
2.8
1.4
—
—
—
0
0
(44790049)
12
72
1.68
0.85
2.8
1.4
—
—
—
0
0
(44806118)
12
72
1.68
0.85
2.8
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
80
1.64
0.85
1.5
1.3
nmol/l
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
47
372
1.28
0.85
3.9
4.0
—
—
—
0
0
(3035880) pH of Pleural fluid
8
45
1.79
0.84
1.3
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
152
1355
1.15
0.82
1.7
1.8
nmol/l
1244.2
1201.9
0.21
117
1008
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
612
5944
1.15
0.82
15.6
14.1
ml/min/173m2
73.7
76.4
2.48
504
4863
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
13
81
1.62
0.81
1.3
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
14
89
1.58
0.81
2.6
1.8
pg
32.7
32.5
0.09
14
89
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
14
89
1.58
0.81
2.3
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
149
1329
1.15
0.80
6.2
4.5
%
23.2
21.6
0.79
86
678
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
20
139
1.45
0.80
1.5
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
96
0.52
0.78
2.8
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
27
200
1.36
0.77
4.2
5.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
36
279
1.30
0.77
1.5
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
53
1.71
0.75
1.1
1.8
—
—
—
0
0
(4010399)
57
470
1.23
0.75
1.7
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
58
480
1.23
0.74
1.5
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
140
1560
0.87
0.73
1.3
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
22
159
1.40
0.73
1.6
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
25
2.01
0.72
1.0
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
14
92
1.53
0.72
1.2
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
39
1.80
0.72
1.1
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
12
76
1.59
0.72
1.7
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
27
203
1.34
0.71
3.1
3.8
mmol/l
3.9
3.9
0.25
27
183
(3004588) Protein electrophoresis panel - Serum or Plasma
58
483
1.22
0.70
2.8
2.6
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
9
58
1.56
0.70
1.3
1.2
u/l
43.0
52.7
—
9
44
(3014051) Protein [Presence] in Urine by Test strip
22
161
1.38
0.69
2.5
2.3
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
5
27
1.86
0.68
1.2
1.3
%
1.3
3.6
—
5
22
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
27
1.86
0.68
4.0
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
28
1.79
0.66
1.0
2.4
%
101.4
95.2
—
5
28
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
18
128
1.42
0.66
2.1
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
11
70
1.58
0.65
1.4
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
166
1514
1.12
0.65
1.9
1.7
pmol/l
53731783.4
15473699.4
0.32
134
1215
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
29
1.73
0.64
1.6
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
30
234
1.29
0.64
1.7
2.5
g/l
0.3
1.2
1.72
24
207
(3027273) Bicarbonate [Moles/volume] in Venous blood
41
333
1.24
0.64
5.3
2.9
mmol/l
25.1
25.4
0.17
41
321
(3028300) Cannabinoids [Presence] in Urine
6
101
0.59
0.62
2.7
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
101
0.59
0.62
2.5
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
101
0.59
0.62
1.3
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
11
71
1.56
0.62
1.4
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
100
885
1.15
0.62
29.9
25.9
inr
1.1
1.3
—
10
110
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
49
1.64
0.62
1.4
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
49
1.64
0.62
1.4
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
49
1.64
0.62
1.4
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
16
113
1.42
0.61
1.1
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
16
113
1.42
0.61
1.2
1.5
mu/l
302.8
286.2
0.14
16
104
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
50
1.61
0.61
1.4
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
50
1.61
0.61
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
50
1.61
0.61
1.4
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
50
1.61
0.61
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
22
165
1.34
0.61
1.5
1.7
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
20
0.00
0.60
0.0
1.3
—
270.3
—
0
13
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
20
148
1.36
0.60
2.2
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
18
243
0.73
0.60
1.5
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
46
382
1.22
0.59
1.5
1.5
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
8
52
1.54
0.59
2.0
2.0
ug/l
2.6
3.4
—
8
47
(3000475) Leukocytes [#/volume] in Synovial fluid
22
166
1.33
0.59
1.5
1.8
e6/l
6060.1
16164.2
0.80
14
120
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
255
1.27
0.59
3.0
2.2
g/l
2.8
3.2
1.54
23
199
(4306422)
10
64
1.57
0.58
1.1
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
313
2966
1.09
0.58
4.1
4.0
—
—
—
0
0
(4268621)
8
53
1.51
0.58
2.3
2.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
16
219
0.72
0.58
3.8
3.1
g/l
0.3
0.2
—
9
77
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
35
1.72
0.57
1.3
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
6
36
1.67
0.56
1.0
1.2
—
—
—
0
0
(3000492) Spirometry study
62
533
1.18
0.56
1.8
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
20
150
1.34
0.56
2.2
1.5
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
5
90
0.55
0.56
1.0
2.4
—
24.6
—
0
23
(3045788) Cell count panel - Pleural fluid
10
65
1.55
0.55
1.3
1.4
—
—
—
0
0
(3020891) Body temperature
33
267
1.25
0.55
4.5
4.3
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
6
38
1.58
0.54
1.3
1.2
u/l
15.8
19.1
—
6
32
(3022806) Fractional oxyhemoglobin in Capillary blood
14
99
1.42
0.54
1.4
1.9
%
88.9
89.8
0.31
14
99
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
21
160
1.32
0.54
2.0
1.7
iu/l
2.8
5.0
—
5
48
(44813793)
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
9
63
1.43
0.52
1.4
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
229
2150
1.09
0.52
2.9
3.0
ng/l
1249.2
1462.3
0.45
187
1846
(3000764) Benzodiazepines [Presence] in Urine
6
100
0.60
0.52
2.5
1.4
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
6
40
1.50
0.51
1.3
1.2
u/l
52.2
78.9
—
6
34
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
24
188
1.29
0.51
1.1
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
17
224
0.75
0.50
1.3
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
22
171
1.30
0.50
1.6
1.5
—
—
—
0
0
(3016750) Collection duration of Urine
6
41
1.47
0.50
3.5
2.4
min
511.7
491.9
—
6
26
(3039443) Prostate specific Ag panel - Serum or Plasma
12
84
1.44
0.49
2.7
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
67
761
0.87
0.49
3.4
4.0
ug/l
4.6
26.6
1.40
58
636
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
26
208
1.26
0.48
4.8
2.7
u/ml
0.3
0.4
0.32
15
114
(3023419) Bacteria identified in Sputum by Culture
13
93
1.40
0.48
2.0
2.7
—
—
—
0
0
(4062490)
7
46
1.53
0.48
2.1
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
34
281
1.22
0.48
2.2
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
143
0.70
0.48
1.4
1.3
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
10
68
1.48
0.47
1.1
1.1
%
112.6
117.5
—
10
61
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
12
85
1.42
0.47
1.2
1.1
—
17.0
—
0
6
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
23
183
1.26
0.45
1.9
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
50
1.40
0.45
1.0
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
12
86
1.40
0.44
1.2
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
51
1.38
0.44
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
139
1.30
0.44
1.2
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
87
961
0.89
0.43
3.5
3.1
ug/l
0.8
0.8
0.27
60
654
(4027681)
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
19
149
1.28
0.42
2.1
2.3
%
17.3
16.2
—
5
66
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
33
1.52
0.41
1.6
5.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
59
1.36
0.41
1.1
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
33
278
1.20
0.40
1.1
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
34
1.47
0.40
3.8
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
34
1.47
0.40
3.8
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
60
1.34
0.40
1.3
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
60
1.34
0.40
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
60
1.34
0.40
1.1
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
35
1.43
0.39
2.4
1.6
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
20
160
1.26
0.39
3.3
3.2
nmol/l
0.8
0.8
0.51
15
127
(21494890) Protein electrophoresis panel - 24 hour Urine
9
70
1.29
0.36
3.8
2.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
12
90
1.34
0.36
2.9
2.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
76
0.66
0.36
1.0
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
42
1.43
0.35
1.0
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
16
126
1.28
0.35
1.6
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
22
181
1.22
0.35
1.3
1.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
169
1596
1.08
0.34
4.3
3.6
%
86.8
89.3
0.58
164
1552
(3002032) Base excess in Venous blood by calculation
68
616
1.11
0.34
4.5
3.3
mmol/l
2.3
2.3
0.01
58
498
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
257
1.17
0.32
2.8
2.2
g/l
11.6
10.5
0.50
23
219
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
143
0.77
0.32
1.2
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
276
1.17
0.32
3.0
2.2
g/l
3.6
3.7
0.33
23
195
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
16
128
1.26
0.32
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
16
128
1.26
0.32
1.4
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
277
1.16
0.31
3.0
2.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
277
1.16
0.31
3.0
2.2
g/l
6.8
7.5
1.15
23
205
(4034850)
17
207
0.82
0.30
11.8
10.9
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
75
1.34
0.30
1.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
80
737
1.10
0.30
1.4
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
55
1.28
0.30
1.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
56
1.25
0.29
2.4
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
19
226
0.84
0.27
1.6
1.7
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
68
625
1.10
0.27
4.5
3.3
kpa
5.8
5.8
0.18
68
604
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
77
1.30
0.26
2.2
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
114
1.23
0.25
1.7
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
114
1.23
0.25
2.5
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
14
115
1.22
0.23
1.6
1.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
31
348
0.89
0.23
9.7
8.6
mmol/l
24.8
24.6
0.13
26
324
(3005033) Fetal Nuchal fold Thickness US
5
38
1.32
0.23
1.0
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
38
1.32
0.23
1.0
1.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
38
1.32
0.23
3.8
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
39
1.28
0.23
6.6
4.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
11
88
1.25
0.22
1.8
1.5
%
45.0
68.4
—
6
59
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
40
1.25
0.22
1.2
1.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
22
191
1.16
0.22
1.6
1.6
mg/l
1.7
2.5
0.65
11
147
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
13
107
1.22
0.21
1.3
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
40
363
1.11
0.21
1.6
1.3
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3001729) Color of Synovial fluid
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
18.2
—
0
10
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.2
—
1.7
—
0
10
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
44
402
1.10
0.21
1.9
1.7
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
20
173
1.16
0.21
1.6
1.9
mg/l
9.6
12.1
0.72
20
159
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
43
1.16
0.21
1.0
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
43
1.16
0.21
1.0
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
43
1.16
0.21
1.0
1.6
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
43
1.16
0.21
1.0
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
89
1.24
0.21
2.7
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
50
542
0.92
0.21
2.0
1.7
%
1.4
1.5
0.96
43
458
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
13
0.00
0.21
0.0
1.4
—
7.1
—
0
7
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(4198724)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
14
0.00
0.20
0.0
1.9
—
3.1
—
0
5
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
53
1.13
0.18
1.3
1.6
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
56
522
1.08
0.18
3.9
2.7
kpa
4.4
4.4
0.05
56
504
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
17
147
1.16
0.18
1.6
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
12
100
1.20
0.18
3.4
2.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
59
1.19
0.18
4.1
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
63
1.11
0.17
1.7
2.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
63
1.11
0.17
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
63
1.11
0.17
1.0
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
15
129
1.17
0.17
3.3
4.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
5
66
0.76
0.17
1.0
1.2
mmol/l
7.9
7.5
—
5
41
(3011288) Drugs identified in Urine by Screen method
5
68
0.73
0.17
4.0
1.7
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
68
1.18
0.16
1.8
2.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
69
1.16
0.16
1.3
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
20
178
1.13
0.15
1.1
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
90
0.78
0.14
1.4
1.5
—
—
—
0
0
(3013512) EKG study
200
2051
0.97
0.14
4.3
4.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
21
189
1.11
0.14
1.3
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
11
94
1.17
0.13
1.8
1.7
nmol/l
39.3
42.6
0.23
11
88
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
18
161
1.12
0.13
1.8
1.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
17
189
0.90
0.12
1.1
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
10
116
0.86
0.12
3.4
2.6
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
5
44
1.14
0.10
2.4
1.3
—
52.9
—
0
7
(3044941) Cell count panel - Synovial fluid
12
106
1.13
0.10
1.5
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
5
47
1.06
0.09
1.4
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
5
47
1.06
0.09
4.6
1.6
e9/l
0.8
0.9
—
5
26
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
47
1.06
0.09
1.2
1.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
61
0.82
0.08
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
60
0.83
0.08
1.0
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
64
1.09
0.08
1.3
1.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
17
156
1.09
0.08
3.2
2.5
ug/min
80.1
64.5
0.12
12
91
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
8
77
1.04
0.07
2.6
3.3
nmol/l
2.1
6.5
—
8
77
(4281824)
7
83
0.84
0.07
1.3
1.1
—
—
—
0
0
(4094501)
18
167
1.08
0.07
1.3
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
99
1.11
0.06
1.1
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
20
187
1.07
0.06
1.4
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
100
0.90
0.06
1.3
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
16
148
1.08
0.06
2.3
2.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
91
1.10
0.04
1.2
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
11
102
1.08
0.03
1.1
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
41
400
1.03
0.02
1.8
2.9
e9/l
4.5
3.9
0.46
32
293
(3014007) Fractional oxyhemoglobin in Arterial blood
42
410
1.03
0.02
8.0
8.4
%
94.4
94.1
0.27
42
405
(3022621) pH of Urine by Test strip
45
459
0.98
0.02
2.8
3.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
40
406
0.98
0.00
1.7
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
11
107
1.03
0.00
2.3
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
11
107
1.03
0.00
1.2
1.1
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
42
415
1.01
0.00
8.0
8.2
%
0.7
0.7
0.21
42
409
(3000991) Gas panel - Venous blood
54
535
1.01
0.00
7.8
7.7
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
58
585
0.99
0.00
6.8
6.3
mmol/l
1.3
1.4
0.49
52
560
(3020961) Endomysium IgA Ab [Titer] in Serum
26
263
0.99
0.00
1.0
1.1
—
193.5
—
0
6
(1002224) Polysomnography panel
19
188
1.01
0.00
1.1
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
16
159
1.01
0.00
2.6
1.6
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
39.5
—
0
6
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
74
0.95
0.00
1.1
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
54
0.93
0.00
1.0
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
21.9
—
0
9
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
59
1.02
0.00
1.3
1.5
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
16.8
—
0
7
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.2
—
0.4
—
0
5
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
5
54
0.93
0.00
2.8
4.4
—
31.5
—
0
14
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
71
0.99
0.00
1.4
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
79
0.89
0.00
3.3
3.6
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.4
—
2.7
—
0
5
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4024509)
7
69
1.01
0.00
1.9
1.5
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_OTHERMELANIN and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_OTHERMELANIN | 0.735 [0.65, 0.83] | < 0.001 |
| Birth year | 0.999 [0.99, 1.01] | 0.778 |
During the follow-up period (1.1.1998 — 31.12.2019), 526 out of 3068 females with L12_OTHERMELANIN died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_OTHERMELANIN | 0.759 [0.63, 0.92] | 0.005 |
| Birth year | 0.988 [0.98, 1.0] | 0.013 |
During the follow-up period (1.1.1998 — 31.12.2019), 253 out of 1356 males with L12_OTHERMELANIN died.
Mortality risk
Mortality risk for people of age
years, who have L12_OTHERMELANIN.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.1% | 0.146% |
| 5 | 0.531% | 0.976% |
| 10 | 1.325% | 2.501% |
| 15 | 2.461% | 4.56% |
| 20 | 4.247% | 7.678% |
Relationships between endpoints
↥Index endpoint: L12_OTHERMELANIN – Other melanin hyperpigmentation
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data